Redsense Medical AB (REDS) — Capital Reinvestment Ratio
Redsense Medical AB (REDS) has a Capital Reinvestment Ratio of 0.14x as of March 2025, meaning it reinvests 0% of its operating cash flow (Skr761.00K) in capital expenditures (Skr105.00K). See debt-free asset ratio of Redsense Medical AB to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Redsense Medical AB Capital Reinvestment Ratio (2020–2020)
This chart tracks Redsense Medical AB's Capital Reinvestment Ratio across 1 annual periods. Check how aggressively does Redsense Medical AB reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Redsense Medical AB (2020–2020)
Year-by-year Capital Reinvestment Ratio for Redsense Medical AB from 2020 to 2020. For live market cap and broader valuation context, see REDS stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 2.15x | Skr17.23 Million | Skr37.08 Million | — |